Ishigami et al.26 found that patients positive for both CEA and CA19-9 had significantly higher frequencies of lymph node metastasis, deeper invasion by the tumor, lower rates of curative resection, and higher rates of hepatic metastasis. The gene discussed is CEACAM5; the disease is metastatic malignant neoplasm in the lymph nodes.